Subject
Pulmonary and Respiratory Medicine,Oncology
Reference14 articles.
1. Treatment of advanced non-small-cell lung cancer: First line, maintenance, and second line– Indian consensus statement update(Under the aegis of Lung Cancer Consortium Asia, Indian Cooperative Oncology Network, Indian Society of Medical and Pediatric Oncology, Molecular Oncology Society, and Association of Physicians of India)
2. The need for third-line treatment in non-small cell lung cancer: an overview of new options;Syrigos;Anticancer Res,2011
3. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005
4. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer;Fukuoka;J Clin Oncol,2003
5. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial;Kris;JAMA,2003